|
US2007022486A1
|
|
Proliferator-Activated Receptor Disruptions, Compositions and Methods Relating Thereto
|
|
US2007143870A1
|
|
SPC7 Serine Protease Gene Disruptions, Compositions and Methods Related Thereto
|
|
US2006160211A1
|
|
Transgenic mice containing, cGMP phosphodiesterase gene disruptions
|
|
US2006172413A1
|
|
Transgenic mice containing melanocyte stimulating hormone receptor gene disruptions
|
|
US2006212955A1
|
|
Transgenic mice containing lymphoid-specific GPCR gene disruptions
|
|
US2006150265A1
|
|
Transgenic mice containing sulfotransferase gene disruptions
|
|
US2006143721A1
|
|
Transgenic mice containing tryptase gene disruptions
|
|
US2006166359A1
|
|
Transgenic mice containing lumulus clotting factor protease-like gene disruptions
|
|
US2006110823A1
|
|
Transgenic mice containing glucocorticoid-induced receptor gene disruptions
|
|
US2006112439A1
|
|
Delta opioid receptor disruptions, compositions and methods related thereto
|
|
US2006041948A1
|
|
Transgenic mice containing chemokine receptor 9A gene disruptions
|
|
US2005289661A1
|
|
CXCR6 chemokine receptor gene disruptions, and compositions and methods related thereto
|
|
US2006031210A1
|
|
Computational method and system for identifying network patterns in complex biological systems data
|
|
WO03026401A2
|
|
Kv3.3b POTASSIUM CHANNEL DISRUPTIONS, COMPOSITIONS AND METHODS RELATED THERETO
|
|
WO03026409A2
|
|
Kv1.7 potassium channel disruptions, compositions and methods relating thereto
|
|
WO03001882A2
|
|
Putative neurotransmitter receptor (pnr) disruptions, compositions and methods relating thereto
|
|
WO02079378A2
|
|
Transgenic mice containing gpcr-like transmembrane protein disruptions
|
|
WO02081658A2
|
|
Transgenic mice containing cacnb4 calcium ion channel gene disruptions
|
|
WO02085094A2
|
|
Transgenic mice containing acylphosphatase gene disruptions
|
|
WO02079439A2
|
|
TRANSGENIC MICE CONTAINING mGluR7 METABOTROPIC GLUTAMATE RECEPTOR GENE DISRUPTIONS
|
